Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span.
暂无分享,去创建一个
Amy N Holland | J. Kopchick | A. Flyvbjerg | K. Coschigano | E. List | Allan Flyvbjerg | Karen T Coschigano | Markus E Riders | Edward O List | John J Kopchick | A. Holland | A. N. Holland
[1] A. Bartke. Delayed aging in Ames dwarf mice. Relationships to endocrine function and body size. , 2000, Results and problems in cell differentiation.
[2] D. Ridgway,et al. Effects of growth hormone antagonists on 3T3-F442A preadipocyte differentiation. , 1995, The Journal of endocrinology.
[3] Andrzej Bartke,et al. Dwarf mice and the ageing process , 1996, Nature.
[4] Matthias Blüher,et al. Extended Longevity in Mice Lacking the Insulin Receptor in Adipose Tissue , 2003, Science.
[5] T. Wagner,et al. Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice. , 1991, Endocrinology.
[6] J. Knapp,et al. Growth hormone (GH) receptors, binding proteins and IGF-I concentrations in the serum of transgenic mice expressing bovine GH agonist or antagonist. , 1998, The Journal of endocrinology.
[7] L. Sjöström,et al. Effects of growth hormone on fat mass and fat distribution. , 1992, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[8] S. Bennett,et al. Pleiotropic effects of growth hormone and insulin-like growth factor (IGF)-1 on biological aging: inferences from moderate caloric-restricted animals. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.
[9] J. Papaconstantinou,et al. The Snell dwarf mutation Pit1 dw can increase life span in mice , 2002, Mechanisms of Ageing and Development.
[10] J. Knapp,et al. The use of transgenic mice in nutrition research. , 1994, The Journal of nutrition.
[11] E. Froesch,et al. Production of carrier proteins for insulin‐like growth factors (IGFs) by rat osteoblastic cells Regulation by IGF I and cortisol , 1989, FEBS letters.
[12] T. Wagner,et al. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[13] R. O’Brien,et al. Regulation of Phosphoenolpyruvate Carboxykinase and Insulin-like Growth Factor-binding Protein-1 Gene Expression by Insulin , 2000, The Journal of Biological Chemistry.
[14] G. Hubbard,et al. Aged-rodent models of long-term growth hormone therapy: lack of deleterious effect on longevity. , 1998, The journals of gerontology. Series A, Biological sciences and medical sciences.
[15] K. Sjögren,et al. Disproportional skeletal growth and markedly decreased bone mineral content in growth hormone receptor -/- mice. , 2000, Biochemical and biophysical research communications.
[16] E. Hafen,et al. Dietary Restriction and Life-Span , 2002, Science.
[17] R. J. Johnson,et al. Interaction of dietary protein content and exogenous porcine growth hormone administration on protein and lipid accretion rates in growing pigs. , 1990, Journal of animal science.
[18] P. Kelly,et al. Studies of insulin, growth hormone and prolactin binding: tissue distribution, species variation and characterization. , 1974, Endocrinology.
[19] M. Schreibman,et al. Vertebrate endocrinology : fundamentals and biomedical implications , 1986 .
[20] T. Wagner,et al. Expression of a mutated bovine growth hormone gene suppresses growth of transgenic mice. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[21] D. Powell,et al. Effect of progestin, antiprogestin, and relaxin on the accumulation of prolactin and insulin-like growth factor-binding protein-1 messenger ribonucleic acid in human endometrial stromal cells. , 1992, Biology of reproduction.
[22] M. Pines,et al. Growth hormone (GH) action in early embryogenesis: expression of a GH-response gene in sites of GH production and action , 2001, Anatomy and Embryology.
[23] H. Green,et al. The generation of insulin-like growth factor-1--sensitive cells by growth hormone action. , 1986, Science.
[24] C. Hsieh,et al. Effects of the Pit1 mutation on the insulin signaling pathway: implications on the longevity of the long-lived Snell dwarf mouse , 2002, Mechanisms of Ageing and Development.
[25] L. Giudice,et al. Insulin-like Growth Factor Binding Protein-1: Recent Findings and New Directions , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[26] C. Hsieh,et al. Implications for the insulin signaling pathway in Snell dwarf mouse longevity: a similarity with the C. elegans longevity paradigm , 2002, Mechanisms of Ageing and Development.
[27] L. Phillips,et al. Molecular regulation of insulin-like growth factor-I and its principal binding protein, IGFBP-3. , 1998, Progress in nucleic acid research and molecular biology.
[28] M. Davidson. Effect of growth hormone on carbohydrate and lipid metabolism. , 1987, Endocrine reviews.
[29] T. Shepard,et al. Human growth hormone , 1960 .
[30] S. Handwerger,et al. Three distinct forms of insulin-like growth factor binding proteins are released by decidual cells in culture. , 1990, Endocrinology.
[31] A. Bartke,et al. Reduced Levels of Thyroid Hormones, Insulin, and Glucose, and Lower Body Core Temperature in the Growth Hormone Receptor/Binding Protein Knockout Mouse , 2001, Experimental biology and medicine.
[32] M. Ridderstråle,et al. Tyrosine phosphorylation of the growth hormone (GH) receptor and Janus tyrosine kinase-2 is involved in the insulin-like actions of GH in primary rat adipocytes. , 1995, Endocrinology.
[33] P. R. Johnson,et al. Body composition of inactivated growth hormone (oMt1a-oGH) transgenic mice: generation of an obese phenotype. , 1997, Growth, development, and aging : GDA.
[34] A. Frantz,et al. HUMAN GROWTH HORMONE. CLINICAL MEASUREMENT, RESPONSE TO HYPOGLYCEMIA AND SUPPRESSION BY CORTICOSTEROIDS. , 1964 .
[35] D. Powell,et al. Activation of the insulin-like growth factor binding protein-1 promoter by progesterone receptor in decidualized human endometrial stromal cells , 1999, Molecular and Cellular Endocrinology.
[36] Z. Laron,et al. The essential role of IGF-I: lessons from the long-term study and treatment of children and adults with Laron syndrome. , 1999, The Journal of clinical endocrinology and metabolism.
[37] J. Kopchick,et al. Transgenic models of growth hormone action. , 1999, Annual review of nutrition.
[38] J. Guevara-Aguirre,et al. Growth hormone (GH) insensitivity due to primary GH receptor deficiency. , 1994, Endocrine reviews.
[39] S. Mohan,et al. Serum Levels of Insulin‐like Growth Factor Binding Proteins (IGFBP)–4 and –5 Correlate with Bone Mineral Density in Growth Hormone (GH)–Deficient Adults and Increase with GH Replacement Therapy , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[40] Z. Laron,et al. Insulin Resistance in Laron Syndrome (Primary Insulin-like Growth Factor-I (IGF-I) Deficiency) and Effect of IGF-I Replacement Therapy , 1997 .
[41] R. Nachreiner,et al. Effects of underfeeding and refeeding on GH and thyroid hormone secretion in young, middle-aged, and old rats , 1990, Experimental Gerontology.
[42] Z. Laron,et al. Body fat in Laron syndrome patients: effect of insulin-like growth factor I treatment. , 1993, Hormone research.
[43] T. Parr. Insulin Exposure and Unifying Aging , 1999, Gerontology.
[44] J. Kopchick,et al. A growth hormone (GH) analog can antagonize the ability of native GH to promote differentiation of 3T3-F442A preadipocytes and stimulate insulin-like and lipolytic activities in primary rat adipocytes. , 1992, Endocrinology.
[45] G. Striker,et al. Effects of streptozotocin treatment in growth hormone (GH) and GH antagonist transgenic mice. , 1995, Endocrinology.
[46] Richard A. Miller,et al. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[47] K.,et al. Metabolic effects of developmental, tissue-, and cell-specific expression of a chimeric phosphoenolpyruvate carboxykinase (GTP)/bovine growth hormone gene in transgenic mice. , 1990, The Journal of biological chemistry.
[48] F. Dominici,et al. Compensatory alterations of insulin signal transduction in liver of growth hormone receptor knockout mice. , 2000, The Journal of endocrinology.
[49] J. A. Scarlett,et al. Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice. , 1999, Diabetes.
[50] J. Meites. Aging: Hypothalamic Catecholamines, Neuroendocrine-Immune Interactions, and Dietary Restriction , 1990, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[51] C. Carter,et al. A critical analysis of the role of growth hormone and IGF-1 in aging and lifespan. , 2002, Trends in genetics : TIG.
[52] R. Marcus,et al. Bone Mineral, Histomorphometry, and Body Composition in Adults with Growth Hormone Receptor Deficiency , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[53] W. Kiess,et al. Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats , 1992, Diabetologia.
[54] D. Clemmons,et al. Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. , 2000, Endocrinology.
[55] B. Cochran,et al. Rapid events in growth hormone action. Induction of c-fos and c-jun transcription in 3T3-F442A preadipocytes. , 1990, Endocrinology.
[56] C. Breese,et al. Influence of age and long-term dietary restriction on plasma insulin-like growth factor-1 (IGF-1), IGF-1 gene expression, and IGF-1 binding proteins. , 1991, Journal of gerontology.
[57] C. Ohlsson,et al. Embryonic stem cells express growth hormone receptors: regulation by retinoic acid. , 1993, Endocrinology.
[58] R. Baron,et al. Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. , 2000, The Journal of clinical investigation.
[59] J. Knapp,et al. Enlargement of Interscapular Brown Adipose Tissue in Growth Hormone Antagonist Transgenic and in Growth Hormone Receptor Gene-Disrupted Dwarf Mice , 2003, Experimental biology and medicine.
[60] M. Ontell,et al. Morphometric analysis of the developing mouse soleus muscle. , 1988, The American journal of anatomy.
[61] R. Leibel,et al. Effects of systemic growth hormone (GH) administration on regional adipose tissue distribution and metabolism in GH-deficient children. , 1989, The Journal of clinical endocrinology and metabolism.
[62] T. Wagner,et al. Glycine 119 of bovine growth hormone is critical for growth-promoting activity. , 1991, Molecular endocrinology.
[63] F. Talamantes,et al. 6 – The Growth Hormone Receptor and Growth Hormone-Binding Protein: Structure, Functions, and Regulation , 1993 .
[64] L. Donahue,et al. Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4. , 1993, The Journal of endocrinology.
[65] D. Flint,et al. Influence of growth hormone deficiency on growth and body composition in rats: site-specific effects upon adipose tissue development. , 1993, The Journal of endocrinology.
[66] T. Parr. Insulin exposure and aging theory. , 1997, Gerontology.
[67] M. Binoux,et al. Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. , 1986, Analytical biochemistry.
[68] R. Leibel,et al. Effects of systemic growth hormone (GH) administration on regional adipose tissue in children with non-GH-deficient short stature. , 1992, The Journal of clinical endocrinology and metabolism.
[69] J. Kopchick,et al. Growth hormone (GH), GH receptor, and signal transduction. , 2000, Molecular genetics and metabolism.
[70] J. Shafer,et al. Demonstration of growth hormone (GH) receptor-associated tyrosine kinase activity in multiple GH-responsive cell types. , 1990, Endocrinology.
[71] T. Unterman,et al. Multihormonal regulation of insulin-like growth factor-binding protein-1 in rat H4IIE hepatoma cells: the dominant role of insulin. , 1991, Endocrinology.
[72] F. Dominici,et al. Increased insulin sensitivity and upregulation of insulin receptor, insulin receptor substrate (IRS)-1 and IRS-2 in liver of Ames dwarf mice. , 2002, The Journal of endocrinology.
[73] A. Fazleabas,et al. Interleukin-1β Induces the Expression of Insulin-Like Growth Factor Binding Protein-1 during Decidualization in the Primate* *This work was supported by NIH Grant HD-36759. , 2000, Endocrinology.
[74] G. Striker,et al. Protection against diabetes-induced nephropathy in growth hormone receptor/binding protein gene-disrupted mice. , 2000, Endocrinology.
[75] J. Runstadler,et al. Obesity and elevated plasma leptin concentration in oMT1A-o growth hormone transgenic mice. , 2001, Obesity research.
[76] M. Waters,et al. Prenatal expression of the growth hormone (GH) receptor/binding protein in the rat: a role for GH in embryonic and fetal development? , 1992, Development.
[77] M. Rechler,et al. Insulin rapidly inhibits insulin-like growth factor-binding protein-1 gene expression in H4-II-E rat hepatoma cells. , 1991, Molecular endocrinology.
[78] J. Knapp,et al. Growth patterns and body composition of transgenic mice expressing mutated bovine somatotropin genes. , 1994, Journal of animal science.
[79] D. Clemmons,et al. Regulation of insulin-like growth factor (IGF) binding proteins in transgenic mice with altered expression of growth hormone and IGF-I. , 1991, Endocrinology.
[80] J. Jansson,et al. Mode of action of pituitary growth hormone on target cells. , 1985, Annual review of physiology.